Air Products & Chemicals 8-K
EarningsGuidance raisedRestructuringImpairment / charge
Louisiana clean-energy complex and Casa Grande green-hydrogen exits drove GAAP losses; FY2026 adjusted EPS guidance rose.
Filed 2026-07-30 06:58 ET
- 2.02 Results of Operations
- 9.01 Financial Statements and Exhibits
Summary
Q3 FY2026 results with Q4 and FY2026 guidance. GAAP losses reflected approximately $2.9B of pre-tax charges for project exits; adjusted EPS increased 12% Y/Y. Air Products raised FY2026 adjusted EPS guidance and now expects approximately $3.5B in FY2026 capital expenditures. The company also announced a Taiwan industrial-gas supply project and finalized a renewable-ammonia marketing and distribution agreement with Yara.
Key Figures
| Metric | Q3 FY2026 | Q3 FY2025 | Y/Y |
|---|---|---|---|
| Sales | $3.16B | $3.02B | 5% |
| Operating income (loss), GAAP | $(2.10)B | $791M | n/m |
| Operating income, non-GAAP adjusted | $810M | $741M | 9% |
| Operating margin, GAAP | (66.3%) | 26.2% | n/m |
| Operating margin, non-GAAP adjusted | 25.6% | 24.5% | 110 bp |
| Net income (loss) attributable to Air Products | $(1.44)B | $714M | n/m |
| Diluted EPS from continuing operations attributable to Air Products, GAAP | $(6.47) | $3.24 | n/m |
| Adjusted diluted EPS, non-GAAP | $3.47 | $3.09 | 12% |
- Business and asset action charges were approximately $2.9B pre-tax, $2.2B after tax, or $9.92 per share, primarily for exiting the Louisiana clean energy complex, the Casa Grande green hydrogen facility, and other smaller clean-energy distribution projects.
- Sales rose on 3% higher volumes, 1% higher pricing and 1% favorable currency. Adjusted operating income benefited from higher on-site volumes, favorable currency and pricing, partly offset by higher costs; adjusted EPS also benefited from higher equity affiliates’ income.
- Nine-month operating cash flow was $3.31B vs $2.00B in the prior-year period.
Guidance
| Metric | Period | Guidance | Prior | Direction |
|---|---|---|---|---|
| Adjusted EPS, non-GAAP | Q4 FY2026 | $3.55-$3.65; 5%-8% Y/Y | — | — |
| Adjusted EPS, non-GAAP | FY2026 | $13.39-$13.49; 11%-12% Y/Y | — | Raised |
| Capital expenditures, non-GAAP | FY2026 | ≈$3.5B | — | — |
Investor Takeaways
- Q4 and full-year adjusted EPS vs guidance will test whether new asset contributions, pricing actions and productivity progress offset macroeconomic uncertainty.
- FY2026 capital expenditures vs the updated expectation will show whether the company is progressing toward lower spending as it optimizes its project portfolio.
The summary is written by an AI model reading the filing.
Model 005 · prompt 01d34d48e3